scispace - formally typeset
G

Guanghui Ma

Researcher at Chinese Academy of Sciences

Publications -  519
Citations -  21012

Guanghui Ma is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Membrane emulsification & Antigen. The author has an hindex of 66, co-authored 497 publications receiving 17108 citations. Previous affiliations of Guanghui Ma include Center for Advanced Materials & Nanjing Tech University.

Papers
More filters
Journal ArticleDOI

Fabrication strategy for amphiphilic microcapsules with narrow size distribution by premix membrane emulsification.

TL;DR: It was found that it was more difficult to obtain PELA microcapsules with narrow size distribution and smooth surface due to its amphiphilic property, compared with the cases of PLA and PLGA.
Journal ArticleDOI

PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: a comparison with glycosylated erythropoietin.

TL;DR: Recombinant human non-glycosylated erythropoietin expressed in E. coli was attached to polyethylene glycol (PEG) chains with different sizes and structures and PEGylation remarkably increased the resistance of rh-ngEpo against plasma degradation.
Journal ArticleDOI

A novel stationary phase derivatized from hydrophilic gigaporous polystyrene-based microspheres for high-speed protein chromatography.

TL;DR: In conclusion, all the results suggested that the gigaporous absorbent is promising for high-speed protein chromatography.
Journal ArticleDOI

Effect of membrane parameters on the size and uniformity in preparing agarose beads by premix membrane emulsification

TL;DR: Agarose microbeads were prepared by premix membrane emulsification with Shirasu-Porous; Glass (SPG) membrane and Polyethylene (PE) membrane as discussed by the authors.
Journal ArticleDOI

Biosynthesis of Self-Assembled Proteinaceous Nanoparticles for Vaccination.

TL;DR: The Nano‐B5 platform can efficiently combine diverse modular components and antigen cargos to efficiently generate a potentially very large diversity of nanovaccine structures using many bacterial species.